Accurate Classification System for Patients With COVID-19 Pneumonitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04302688|
Recruitment Status : Completed
First Posted : March 10, 2020
Last Update Posted : March 10, 2020
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease|
- First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group.
- Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility.
- Compared with SEPSIS and CURB-65 grading system with the grading system we established.
|Study Type :||Observational|
|Actual Enrollment :||669 participants|
|Official Title:||Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram|
|Actual Study Start Date :||December 10, 2019|
|Actual Primary Completion Date :||February 10, 2020|
|Actual Study Completion Date :||March 4, 2020|
The 445 patients were grouped in chronological order.
The remaining 224 patients.
- survival status [ Time Frame: 10 December 2019 to 10 February 2020 ]survival status as of February 24, 2020
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||Child, Adult, Older Adult|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.
- Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
- Suspected patient review refers to the negative nucleic acid test.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04302688
|Renmin Hospital of Wuhan University|
|Wuhan, Hubei, China, 430060|
|Principal Investigator:||Qiong Gong, MD.||Renmin Hospital of Wuhan University|
|Responsible Party:||Gong Qiong, Professor, Renmin Hospital of Wuhan University|
|Other Study ID Numbers:||
|First Posted:||March 10, 2020 Key Record Dates|
|Last Update Posted:||March 10, 2020|
|Last Verified:||March 2020|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Plan Description:||Not going to share for the time being.|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
Respiratory Tract Infections
Respiratory Tract Diseases